BioProcess International: Cell and Gene Therapy Data Management

Article

At the Phacilitate Leaders World and World Stem Cell Summit 2019, held 22-25 Jan, Steve Goodman (Head of Drug Product Manufacturing at Bluebird Bio) and Robert Di Scipio (CEO of Skyland Analytics, now part of IDBS) shared the podium to address what the product and process data management ecosystem looks like for cell and gene therapy (CGT) development and manufacturing.

Key points: 

  • Data challenges of CGT supply chains
  • Data management by design is the key
  • Software as a service is the future of data management
See a demonstration

More whitepapers

The IDBS GxP Cloud

Customers and regulators expect the highest level of data integrity to get the most out of data and ensure compliance.